NEW ORLEANS -- Patients at a community health center who had type 2 diabetes and a high risk of atherosclerotic ...

Powerful weight-loss drugs are expanding use of U.S. health care as patients starting prescriptions are diagnosed with ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

By Anna Ringstrom and Maggie Fick STOCKHOLM/LONDON (Reuters) -Danish drugmaker Novo Nordisk will invest 8.5 billion crowns ...

Landmark publication in leading ophthalmology research journal demonstrates the power of 4DMT’s Therapeutic Vector Evolution platform to invent ...

Mike Plante struggled with his weight for years, but within six months of starting with the injection drug semaglutide, a ...

Danish drugmaker Novo Nordisk will invest 8.5 billion crowns ($1.20 billion) in a new facility in Odense, Denmark, for the ...

Mike Plante struggled with his weight for years, but within six months of starting with the injection drug semaglutide, a medication for diabetes that’s also being used for weight-loss, he’s down 65 ...

Weight loss medication like Ozempic, Mounjaro, and Wegovy are among the most well-known, but how do you know which one is ...

Researchers conducted a retrospective study to assess serum inflammatory biomarkers in patients with different subtypes of ...

diabetic macular edema and macular edema following retinal vein occlusion. Vabysmo PFS delivers the same medicine as the currently available 6.0 mg Vabysmo vials in a ready-to-use format. The company ...